These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetics and prognosis for uveal melanoma in Korean patients. Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015 [TBL] [Abstract][Full Text] [Related]
4. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016 [TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma: genetic aspects. Singh AD; Damato B; Howard P; Harbour JW Ophthalmol Clin North Am; 2005 Mar; 18(1):85-97, viii. PubMed ID: 15763194 [TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438 [No Abstract] [Full Text] [Related]
7. Chromosomal aberrations in iris melanomas. Mensink HW; Vaarwater J; de Keizer RJ; de Wolff-Rouendaal D; Mooy CM; de Klein A; Paridaens D Br J Ophthalmol; 2011 Mar; 95(3):424-8. PubMed ID: 20881029 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of uveal melanoma: are we there yet? Robertson DM Arch Ophthalmol; 2008 Mar; 126(3):409-10. PubMed ID: 18332323 [No Abstract] [Full Text] [Related]
9. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284 [TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662 [TBL] [Abstract][Full Text] [Related]
12. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564 [TBL] [Abstract][Full Text] [Related]
13. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594 [TBL] [Abstract][Full Text] [Related]
14. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
15. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575 [TBL] [Abstract][Full Text] [Related]
16. Variability of chromosomes in the VUP permanent cell line derived from uveal malignant melanoma. Vrba M; Cíhalová V; Jurásková V Neoplasma; 2002; 49(3):184-8. PubMed ID: 12098005 [TBL] [Abstract][Full Text] [Related]